Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors — Results from a systematic review and meta-analysis of randomized controlled trials

Numerous studies have suggested that oral supplementation with resveratrol exerts cardioprotective effects, but evidence of the effects on C-reactive protein (CRP) plasma levels and other cardiovascular (CV) risk factors is inconclusive. Therefore, we performed a meta-analysis to evaluate the effica...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	International journal of cardiology Ročník 189; s. 47 - 55
Hlavní autoři:	Sahebkar, Amirhossein, Serban, Corina, Ursoniu, Sorin, Wong, Nathan D., Muntner, Paul, Graham, Ian M., Mikhailidis, Dimitri P., Rizzo, Manfredi, Rysz, Jacek, Sperling, Laurence S., Lip, Gregory Y.H., Banach, Maciej
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Netherlands Elsevier B.V 15.06.2015
Témata:	Antioxidants Antioxidants - administration & dosage C reactive protein C-Reactive Protein - drug effects C-Reactive Protein - metabolism Cardiotonic Agents Cardiovascular Cardiovascular Diseases - drug therapy Cardiovascular Diseases - mortality Cardiovascular Diseases - prevention & control CRP Female Humans Inflammation Male Prognosis Randomized Controlled Trials as Topic Resveratrol Risk Assessment Severity of Illness Index Stilbenes - administration & dosage Survival Rate Treatment Outcome CRP Antioxidants Inflammation C reactive protein Resveratrol
ISSN:	0167-5273, 1874-1754, 1874-1754
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!